Premium
Treace Medical Concepts Inc (TMCI)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. John T. TreaceFounder, Chairman & CEO | 50,00k | 177,92k | Achat | 3,56 | 12,65M | 0,40% |
| 2026-05-26 | Mr. John T. TreaceFounder, Chairman & CEO | 115,52k | 340,59k | Achat | 2,79 - 3,02 | 12,06M | 0,97% |
| 2026-05-12 | Mr. John T. TreaceFounder, Chairman & CEO | 153,76k | 375,51k | Achat | 2,17 - 2,62 | 11,94M | 1,30% |
| 2026-04-17 | Mr. Mark L. HairCFO | -11,55k | 0,00 | Sale to Issuer | - | 165,31k | -6,53% |
| 2026-03-08 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -1,85k | 0,00 | Sale to Issuer | - | 161,06k | -1,14% |
| 2026-03-08 | Mr. John T. TreaceFounder, Chairman & CEO | -7,08k | 0,00 | Sale to Issuer | - | 11,79M | -0,06% |
| 2026-03-08 | Mr. Mark L. HairCFO | -4,66k | 0,00 | Sale to Issuer | - | 151,86k | -2,98% |
| 2026-03-08 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | -1,80k | 0,00 | Sale to Issuer | - | 200,76k | -0,89% |
| 2026-02-10 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | 16,88k | 17,72k | Derivative Exercise and Retained Stock | 1,05 | 195,18k | 9,46% |
| 2026-01-22 | Mr. John T. TreaceFounder, Chairman & CEO | -14,25k | 0,00 | Sale to Issuer | - | 11,76M | -0,12% |
| 2026-01-21 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | 53,50k | 38,52k | Derivative Exercise and Retained Stock | 0,72 | 178,31k | 42,87% |
| 2026-01-22 | Mr. Mark L. HairCFO | -17,04k | 0,00 | Sale to Issuer | - | 142,07k | -10,71% |
| 2026-01-22 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -9,45k | 0,00 | Sale to Issuer | - | 155,32k | -5,74% |
| 2026-01-10 | Mr. Mark L. HairCFO | -8,72k | 0,00 | Sale to Issuer | - | 112,24k | -7,21% |
| 2026-01-10 | Mr. John T. TreaceFounder, Chairman & CEO | -13,22k | 0,00 | Sale to Issuer | - | 11,74M | -0,11% |
| 2026-01-10 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -4,54k | 0,00 | Sale to Issuer | - | 132,89k | -3,31% |
| 2025-12-01 | Mr. Gaetano M. GuglielminoInitié | -22,10k | 0,00 | Sale to Issuer | - | 68,65k | -24,35% |
| 2025-10-25 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -984,00 | 0,00 | Sale to Issuer | - | 122,11k | -0,80% |
| 2025-10-24 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | -208,00 | 0,00 | Sale to Issuer | - | 89,65k | -0,23% |
| 2025-09-30 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -16,88k | 0,00 | Sale to Issuer | - | 120,60k | -12,28% |
| 2025-08-09 | Mr. Aaron J. BeruttiSVP of Commercial Excellence | -4,91k | 0,00 | Sale to Issuer | - | 23,14k | -17,50% |
| 2025-08-09 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | -9,81k | 0,00 | Sale to Issuer | - | 89,01k | -9,93% |
| 2025-08-09 | Mr. Mark L. HairCFO | -22,21k | 0,00 | Sale to Issuer | - | 97,74k | -18,52% |
| 2025-08-09 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -10,52k | 0,00 | Sale to Issuer | - | 86,05k | -10,89% |
| 2025-07-18 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | 33,44k | 24,00k | Derivative Exercise and Retained Stock | 0,72 | 58,52k | 133,29% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
